Curative Biotechnology, Inc.
CUBT
$0.0118
$0.00032.61%
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -5.04M | -4.64M | -5.94M | -5.34M | -9.00M |
| Total Depreciation and Amortization | 1.70K | 1.70K | 1.70K | 500.00 | 6.10K |
| Total Amortization of Deferred Charges | 550.60K | 285.80K | 39.60K | 6.30K | 52.60K |
| Total Other Non-Cash Items | 555.40K | 790.10K | 2.91M | 3.18M | 7.54M |
| Change in Net Operating Assets | 1.68M | 1.07M | 427.50K | 549.10K | 228.80K |
| Cash from Operations | -2.25M | -2.49M | -2.57M | -1.60M | -1.18M |
| Capital Expenditure | -6.80K | -6.80K | -6.80K | -6.80K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -77.00K | -46.70K | -42.30K | -14.50K | -48.80K |
| Cash from Investing | -83.80K | -53.50K | -49.10K | -21.30K | -48.80K |
| Total Debt Issued | 1.25M | 1.23M | 1.03M | 180.00K | 495.00K |
| Total Debt Repaid | -86.70K | -52.00K | -76.00K | -50.00K | -98.10K |
| Issuance of Common Stock | 548.00K | 973.00K | 1.57M | 2.10M | 1.55M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -109.40K | -204.00K | -161.70K | -93.00K | -- |
| Cash from Financing | 1.60M | 1.94M | 2.36M | 2.14M | 1.95M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -731.20K | -601.30K | -254.30K | 509.60K | 720.80K |
